India
· Delayed Price · Currency is INR JFL Life Sciences Statistics
Total Valuation
JFL Life Sciences has a market cap or net worth of INR 813.33 million. The enterprise value is 869.93 million.
| Market Cap | 813.33M |
| Enterprise Value | 869.93M |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | Sep 13, 2024 |
Share Statistics
JFL Life Sciences has 33.00 million shares outstanding. The number of shares has increased by 13.50% in one year.
| Shares Outstanding | 33.00M |
| Shares Change (YoY) | +13.50% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 24.57.
| PE Ratio | 24.57 |
| Forward PE | n/a |
| PS Ratio | 1.75 |
| PB Ratio | 2.28 |
| P/FCF Ratio | 35.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.08, with an EV/FCF ratio of 38.49.
| EV / Earnings | 26.28 |
| EV / Sales | 1.87 |
| EV / EBITDA | 19.08 |
| EV / EBIT | 21.11 |
| EV / FCF | 38.49 |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.16 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 1.25 |
| Debt / FCF | 2.52 |
| Interest Coverage | 4.96 |
Financial Efficiency
Return on equity (ROE) is 9.76% and return on invested capital (ROIC) is 6.38%.
| Return on Equity (ROE) | 9.76% |
| Return on Assets (ROA) | 4.87% |
| Return on Capital (ROIC) | 6.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.88 |
| Inventory Turnover | 2.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.92% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +50.92% |
| 50-Day Moving Average | 21.37 |
| 200-Day Moving Average | 16.39 |
| Relative Strength Index (RSI) | 61.03 |
| Average Volume (20 Days) | 217,200 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JFL Life Sciences had revenue of INR 465.50 million and earned 33.10 million in profits. Earnings per share was 1.00.
| Revenue | 465.50M |
| Gross Profit | 77.00M |
| Operating Income | 41.20M |
| Pretax Income | 38.10M |
| Net Income | 33.10M |
| EBITDA | 45.60M |
| EBIT | 41.20M |
| Earnings Per Share (EPS) | 1.00 |
Balance Sheet
The company has 300,000 in cash and 56.90 million in debt, giving a net cash position of -56.60 million or -1.72 per share.
| Cash & Cash Equivalents | 300,000 |
| Total Debt | 56.90M |
| Net Cash | -56.60M |
| Net Cash Per Share | -1.72 |
| Equity (Book Value) | 355.80M |
| Book Value Per Share | 10.79 |
| Working Capital | 231.50M |
Cash Flow
In the last 12 months, operating cash flow was 83.60 million and capital expenditures -61.00 million, giving a free cash flow of 22.60 million.
| Operating Cash Flow | 83.60M |
| Capital Expenditures | -61.00M |
| Free Cash Flow | 22.60M |
| FCF Per Share | 0.68 |
Margins
Gross margin is 16.54%, with operating and profit margins of 8.85% and 7.11%.
| Gross Margin | 16.54% |
| Operating Margin | 8.85% |
| Pretax Margin | 8.18% |
| Profit Margin | 7.11% |
| EBITDA Margin | 9.80% |
| EBIT Margin | 8.85% |
| FCF Margin | 4.85% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 0.34%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 0.34% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.50% |
| Shareholder Yield | -13.16% |
| Earnings Yield | 4.07% |
| FCF Yield | 2.78% |
Stock Splits
The last stock split was on September 24, 2024. It was a forward split with a ratio of 3.
| Last Split Date | Sep 24, 2024 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |